Doylestown, PA, United States of America

Taekyu Lee

USPTO Granted Patents = 33 


 

Average Co-Inventor Count = 6.4

ph-index = 14

Forward Citations = 1,338(Granted Patents)


Location History:

  • Wilmington, DE (US) (2003 - 2007)
  • Doylestown, PA (US) (2005 - 2010)
  • Brentwood, TN (US) (2018 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Title: Inventor Profile: Taekyu Lee

Introduction

Taekyu Lee, a prolific inventor located in Doylestown, PA, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 20 patents. His work primarily focuses on compounds that interact with cannabinoid and serotonin receptors, showcasing his dedication to advancing medical treatments.

Latest Patents

One of Taekyu Lee's latest patents is titled "Bicyclic heterocycles as cannabinoid-1 receptor modulators." This application describes a range of compounds, pharmaceutical compositions, and methods of treatment utilizing these compounds. The focus is on compounds represented by Formula I, which may include various forms such as prodrugs, solvates, and pharmaceutically acceptable salts. These compounds aim to provide therapeutic benefits both alone and in combination with other agents.

Another recent patent is for "Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists." This application also details compounds according to Formula I, comprising various forms, and discusses their potential to treat a range of diseases and disorders linked to serotonin receptor modulation. The therapeutic applications include addressing metabolic diseases, central nervous system disorders, cephalic pain, migraine, and gastrointestinal issues, reflecting the broad impact of his research.

Career Highlights

Throughout his career, Taekyu Lee has played vital roles in two prominent pharmaceutical companies: Bristol-Myers Squibb Pharma Company and Bristol-Myers Squibb Company. His work at these organizations has led to the development of innovative therapeutic compounds aimed at improving patient outcomes.

Collaborations

Lee has collaborated with esteemed colleagues in the field, including Wenting Chen and Albert Jean Robichaud. These partnerships have facilitated the exploration of new avenues in pharmaceutical research, strengthening the impact of their collective work on medical science.

Conclusion

Taekyu Lee’s contributions to pharmaceutical innovations have resulted in the development of significant therapeutic agents aimed at treating various medical conditions. With a robust portfolio of patents and fruitful collaborations, he continues to be an influential figure in the field of pharmacology, with promising implications for future medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…